<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Linda Chanamé Pinedo</style></author><author><style face="normal" font="default" size="100%">Franz, Eelco</style></author><author><style face="normal" font="default" size="100%">Maaike van den Beld</style></author><author><style face="normal" font="default" size="100%">Nina Van Goethem</style></author><author><style face="normal" font="default" size="100%">Wesley Mattheus</style></author><author><style face="normal" font="default" size="100%">Kees Veldman</style></author><author><style face="normal" font="default" size="100%">Thijs Bosch</style></author><author><style face="normal" font="default" size="100%">Lapo Mughini-Gras</style></author><author><style face="normal" font="default" size="100%">Roan Pijnacker</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Changing epidemiology of  Enteritidis human infections in the Netherlands and Belgium, 2006 to 2019: a registry-based population study.</style></title><secondary-title><style face="normal" font="default" size="100%">Euro Surveill</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Animals</style></keyword><keyword><style  face="normal" font="default" size="100%">Belgium</style></keyword><keyword><style  face="normal" font="default" size="100%">Disease Outbreaks</style></keyword><keyword><style  face="normal" font="default" size="100%">Humans</style></keyword><keyword><style  face="normal" font="default" size="100%">Netherlands</style></keyword><keyword><style  face="normal" font="default" size="100%">REGISTRIES</style></keyword><keyword><style  face="normal" font="default" size="100%">Salmonella enteritidis</style></keyword><keyword><style  face="normal" font="default" size="100%">Salmonella Infections</style></keyword><keyword><style  face="normal" font="default" size="100%">Travel</style></keyword><keyword><style  face="normal" font="default" size="100%">Travel-Related Illness</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2022</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2022 09</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">27</style></volume><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p&gt;BackgroundSalmonellosis remains the second most common zoonosis in the European Union despite a long-term decreasing trend. However, this trend has been reported to have stagnated in recent years, particularly for serotype Enteritidis (SE).AimTo describe temporal changes in the incidence of SE human infections, and in its associated factors between 2006 and 2019. In addition, we aim to determine which factors influenced the stagnated trend seen in recent years.MethodsData on culture-confirmed SE human infections from national surveillance registries in the Netherlands and Belgium between 2006 and 2019 were analysed using multivariable negative-binomial regression models with restricted cubic splines.ResultsSE incidence was significantly higher in summer and autumn than winter, in persons aged 0-4 years and 5-14 years than in persons ≥ 60 years, and increased with increasing proportions of travel-related and resistant SE infections. SE incidence decreased significantly in both countries until 2015, followed by an increasing trend, which was particularly pronounced in the Netherlands. Potential SE outbreaks in both countries and invasive infections in the Netherlands also increased after 2015.ConclusionThe increase in potential outbreaks and invasive infections since 2015 may partially explain the observed reversal of the decreasing trend. While these results provide insights into the possible causes of this trend reversal, attention should also be given to factors known to influence SE epidemiology at primary (animal) production and pathogen genomic levels.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">38</style></issue></record></records></xml>